DaVita Inc.

DVA Healthcare Medical Care Facilities

DaVita Inc.’s revenue for fiscal 2025 (year ended December 2025) was $13.6 billion, up 6.46% from fiscal 2024. In the quarter to June 2026, revenue grew 5.17%, EPS grew 56.5%, free cash flow grew 49.4% and total debt rose 4.40%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for three consecutive years.

187.31 1.85 −0.98%
Market cap
$12.1B
P/E
15.0×
Fwd P/E
13.1×
Dividend yield
—
F-score
6/9
Altman Z
1.49
Beneish M
−2.59
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

13.37 11.23 13.97 17.83
P/S ratio
0.72 0.62 0.75 1.03
P/FCF ratio
6.36 5.56 6.12 8.01
P/Operating CF
11.38 15.60 32.28 29.41
P/B ratio
0.00 0.00 0.00 0.00
Price to Tangible BV
0.00 0.00 0.00 0.00
EV/Sales
1.43 1.33 1.47 1.75
EV/EBITDA
6.93 6.57 7.25 8.62
EV/Operating CF
10.06 9.61 10.02 11.15
EV/FCF
12.65 11.94 12.00 13.59
Quick Ratio
1.26 1.19 1.31 1.36
Current Ratio
1.36 1.29 1.42 1.47
Net Debt/EBITDA
13.87 12.96 15.10 13.45
Debt/Assets
58.68% 59.91% 61.22% 61.08%
Debt/Equity
(33.86) (28.02) (22.49) (22.44)
Asset Turnover
0.76 0.78 0.80 0.80
Operating CF/Net income
5.60 2.31 1.62 1.85
Capex/Depreciation
(0.88) (0.77) (0.55) (1.01)
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
12.12% 13.05% 12.35% 11.91%
Intangible Assets out of Total Assets
0.44 0.44 0.45 0.44
Share Based Compensation of Revenue
1.14% 1.06% 0.82% 0.73%
Graham Net Nets
(1.44) (1.64) (1.34) (0.97)
Graham Number
0.00 0.00 0.00 0.00
Earnings Yield
7.48% 8.91% 7.16% 5.61%
Free Cash Flow Yield
15.72% 18.00% 16.35% 12.48%
Revenue per Share
47.45 48.77 50.68 54.86
Operating CF per Share
11.68 7.28 4.76 7.57
Capex per Share
(2.17) (1.93) (1.46) (2.61)
Free Cash Flow per Share
9.51 5.35 3.30 4.95
Cash per Share
11.46 10.54 11.11 11.91
Shareholders Equity per Share
(4.22) (5.03) (7.07) (7.44)
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
(4.22) (5.03) (7.07) (7.44)
Free Cash Flow
685.38 397.13 222.53 320.92
Working Capital
1,094.70 916.37 1,195.22 1,334.21
Capital Expenditures
(156.15) (143.59) (98.30) (169.15)
Net Current Asset Value
(13,748.29) (13,795.83) (13,913.02) (14,001.83)
EV/EBIT
9.30 8.87 9.74 11.50
Capex to Sales
0.05 0.04 0.03 0.05
Price to Operating Income
4.68 4.13 4.96 6.77
Other line items
Average Receivables
2,808.60 2,758.36 2,885.38 3,060.22
Average Payables
571.92 621.67 643.70 655.14
Average Inventory
134.05 147.59 146.07 148.92
Average Assets
17,529.82 17,382.69 17,309.20 17,601.23
Average Common Equity
141.22 11.07 (241.45) (294.97)

Fold the line items

Columns are period end dates